Advanced search
Publication Cover
Leukemia & Lymphoma Volume 55, 2014 - Issue 12
Submit an article Journal homepage
803
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Eltrombopag can overcome the anti-megakaryopoietic effects of lenalidomide without increasing proliferation of the malignant myelodysplastic syndrome/acute myelogenous leukemia clone

Roni TamariDivision of Hematologic Malignancies, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
,
Carolina SchinkeDivision of Hematologic Malignancies, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
,
Tushar BhagatDivision of Hematologic Malignancies, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
,
Michael RothDivision of Hematologic Malignancies, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
,
Ira BraunschweigDivision of Hematologic Malignancies, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
,
Britta WillDivision of Hematologic Malignancies, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
,
Ulrich SteidlDivision of Hematologic Malignancies, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
&
Amit VermaDivision of Hematologic Malignancies, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USACorrespondence[email protected] [email protected]
 show all
Pages 2901-2906 | Received 20 Sep 2013, Accepted 10 Feb 2014, Published online: 20 Mar 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sangeetha Venugopal, Rory M. Shallis & Amer M. Zeidan. (2023) Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress. Expert Review of Anticancer Therapy 0:0, pages 1-9.
Read now
Mingyue Shi, Fangfang Xu, Xiawan Yang, Yanliang Bai, Junwei Niu, Emmanuel Kwateng Drokow, Mingyi Chen, Yuqing Chen & Kai Sun. (2019) The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells. Cancer Management and Research 11, pages 8229-8238.
Read now

Articles from other publishers (9)

Jesus D. Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, William B. Donnellan, Jesus Berdeja, Prafulla Bhagat, Karen Fehn, Cassady Remy, Sakshi Jasra, Mohammed Kazemi, Kith Pradhan, Mimi Kim, Ioannis Mantzaris, R. Alejandro Sica, Nishi Shah, Mendel Goldfinger, Noah Kornblum, Kira Gritsman, Ira Braunschweig, Ulrich Steidl, Britta Will, Aditi Shastri & Amit Verma. (2023) Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial. Clinical Cancer Research 29:1, pages 60-66.
Crossref
David P. Steensma & Richard M. Stone. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1798 1820.e11 .
James Bussel, Austin Kulasekararaj, Nichola Cooper, Amit Verma, Ulrich Steidl, John W. Semple & Britta Will. (2019) Mechanisms and therapeutic prospects of thrombopoietin receptor agonists. Seminars in Hematology 56:4, pages 262-278.
Crossref
Rena Buckstein. (2019) Eltrombopag use in higher risk myeloid cancers: fitting a square “pag” into a round hole?. The Lancet Haematology 6:3, pages e111-e112.
Crossref
Esther N Oliva, Caterina Alati, Valeria Santini, Antonella Poloni, Alfredo Molteni, Pasquale Niscola, Flavia Salvi, Grazia Sanpaolo, Enrico Balleari, Ulrich Germing, Pierre Fenaux, Aspasia Stamatoullas, Giuseppe A Palumbo, Prassede Salutari, Stefana Impera, Paolo Avanzini, Agostino Cortelezzi, Anna Marina Liberati, Paola Carluccio, Francesco Buccisano, Maria Teresa Voso, Stefano Mancini, Austin Kulasekararaj, Fortunato Morabito, Monica Bocchia, Patrizia Cufari, Maria Antonietta Aloe Spiriti, Irene Santacaterina, Maria Grazia D'Errigo, Irene Bova, Gina Zini & Roberto Latagliata. (2017) Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial. The Lancet Haematology 4:3, pages e127-e136.
Crossref
Michael D. Tarantino & Sarah Chalmers. 2017. Platelets in Thrombotic and Non-Thrombotic Disorders. Platelets in Thrombotic and Non-Thrombotic Disorders 1417 1429 .
W Li, K Morrone, S Kambhampati, B Will, U Steidl & A Verma. (2015) Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies. Leukemia 30:3, pages 536-544.
Crossref
Y. Saunthararajah. 2016. Cancer Stem Cells. Cancer Stem Cells 101 119 .
Valeria Santini & Pierre Fenaux. (2015) Treatment of Myelodysplastic Syndrome with Thrombomimetic Drugs. Seminars in Hematology 52:1, pages 38-45.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.